Other abnormal tumor markers Save
ICD-10 code: R97.8
Chapter: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Other Abnormal Tumor Markers
Tumor markers are substances that are produced by cancerous cells or in response to cancer. They can be detected in the blood, urine, or tissue of a person with cancer. Tumor markers can be used to diagnose cancer, monitor the progression of the disease, and determine the effectiveness of treatment. However, not all cancers produce the same tumor markers. Here are some other abnormal tumor markers that you should be aware of:
- Alpha-fetoprotein (AFP) - This tumor marker is associated with liver cancer and germ cell tumors. Elevated levels of AFP may indicate the presence of these cancers. However, AFP levels can also be elevated in pregnant women or individuals with liver disease.
- Human chorionic gonadotropin (HCG) - This tumor marker is associated with germ cell tumors, such as testicular and ovarian cancers. HCG levels are also elevated during pregnancy and can be used to detect pregnancy.
- Carcinoembryonic antigen (CEA) - This tumor marker is associated with colorectal, pancreatic, and lung cancers. Elevated levels of CEA may indicate the presence of these cancers. However, CEA levels can also be elevated in individuals with inflammatory bowel disease or smokers.
- CA 15-3 - This tumor marker is associated with breast cancer. Elevated levels of CA 15-3 may indicate the presence of breast cancer. However, CA 15-3 levels can also be elevated in individuals with benign breast conditions.
- CA 19-9 - This tumor marker is associated with pancreatic, bile duct, and gastrointestinal cancers. Elevated levels of CA 19-9 may indicate the presence of these cancers. However, CA 19-9 levels can also be elevated in individuals with pancreatitis or biliary tract obstruction.
It is important to note that the presence of an abnormal tumor marker does not necessarily mean that an individual has cancer. Elevated levels of tumor markers can also be caused by other conditions, such as inflammation or infection. Therefore, abnormal tumor markers should be interpreted in conjunction with other diagnostic tests, such as imaging studies or biopsies.
If you have an abnormal tumor marker, your healthcare provider may recommend further testing to determine the underlying cause. Early detection and treatment of cancer can improve outcomes and increase the chances of survival.